Abstract
Psoriasis is a chronic genetically determined disease of a multifactorial nature associated with immune-mediated inflammation and characterized by a recurrent course with frequent associative damage to other organs and systems.
According to global recommendations, nowadays, despite the era of biologic therapy, phototherapy (PUVA and UVB) continues to occupy its important niche in the treatment of moderate-to-severe psoriasis, due to the pathogenetically justified therapeutic effect, safety and low cost of procedures.
The review provides detailed data on the mechanism of action, the effectiveness of phototherapy; as well as potential biomarkers of psoriasis (calprotectin, lipocalin 2, resistin), which can enhance an accuracy assessment of the effectiveness of the treatment and, if necessary, its timely correction, which will allow faster achievement of the desired effect resulting in improvement of the quality of patients lives.
Reference64 articles.
1. Olisova OY, Teplyuk NP, Pinegin VB. Modern methodes of psoriasis treatment. Russ J Med. 2015;(9):483–486. (In Russ).
2. Psoriasis
3. Ministry of Health of Russian Federation. The incidence of Russian population in 2020. Statistical data. Part 1. Moscow; 2021. Р. 111–112. (In Russ).
4. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy
5. Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease